Read our Privacy noticeA new study suggests giving Mounjaro to type 2 diabetes patients could reduce the risk of heart attacks in people also living with heart disease. Those receiving the drug were found to be 33% less likely to suffer a heart attack when compared to patients on another type 2 diabetes medication. The US study, published in The BMJ, involved almost 53,000 people diagnosed with type 2 diabetes and heart disease. Experts used data to compare rates of alopecia hair loss in adults using GLP-1s to manage diabetes with those on other drugs. It has also received 148 reports of hair loss linked to semaglutide, alongside 164 reports last year.